April, 2024
April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Amer Zeidan: Just an unbelievable cascade of news for magrolimab
Feb 23, 2024, 10:51

Amer Zeidan: Just an unbelievable cascade of news for magrolimab

Amer Zeidan shared on X:

“Just an unbelievable cascade of news for magrolimab … Gilead Sciences Passes Enrollment for Cancer Treatment in Solid Tumor Trials.”

View additional information.
Source: Amer Zeidan/X

Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center. Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.